Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obsessive-Compulsive Disorder | 50 | 2024 | 1508 | 5.830 |
Why?
|
Deep Brain Stimulation | 34 | 2024 | 851 | 4.910 |
Why?
|
Psychosurgery | 11 | 2023 | 86 | 2.300 |
Why?
|
Prefrontal Cortex | 25 | 2022 | 2238 | 1.950 |
Why?
|
Trichotillomania | 10 | 2022 | 178 | 1.930 |
Why?
|
Internal Capsule | 6 | 2023 | 138 | 1.820 |
Why?
|
Depressive Disorder, Major | 32 | 2024 | 4818 | 1.790 |
Why?
|
Gyrus Cinguli | 20 | 2021 | 1135 | 1.720 |
Why?
|
Bipolar Disorder | 27 | 2023 | 5130 | 1.330 |
Why?
|
Limbic System | 8 | 2014 | 424 | 1.260 |
Why?
|
Electric Stimulation Therapy | 6 | 2022 | 635 | 1.200 |
Why?
|
Thalamus | 11 | 2024 | 1047 | 1.190 |
Why?
|
Emotions | 13 | 2024 | 2767 | 1.090 |
Why?
|
Galvanic Skin Response | 5 | 2024 | 359 | 1.080 |
Why?
|
Amygdala | 9 | 2024 | 1380 | 1.010 |
Why?
|
Fear | 5 | 2024 | 1495 | 0.990 |
Why?
|
Brain | 52 | 2024 | 27360 | 0.990 |
Why?
|
Impulsive Behavior | 3 | 2024 | 345 | 0.960 |
Why?
|
Transcranial Magnetic Stimulation | 7 | 2024 | 1490 | 0.930 |
Why?
|
Psychotherapy | 9 | 2024 | 1654 | 0.900 |
Why?
|
Brain Mapping | 29 | 2024 | 6685 | 0.880 |
Why?
|
Magnetic Resonance Imaging | 59 | 2024 | 36743 | 0.860 |
Why?
|
Citalopram | 6 | 2021 | 401 | 0.850 |
Why?
|
Tomography, Emission-Computed | 14 | 2006 | 1126 | 0.820 |
Why?
|
Subthalamic Nucleus | 3 | 2021 | 203 | 0.800 |
Why?
|
Extinction, Psychological | 4 | 2018 | 367 | 0.760 |
Why?
|
Anger | 6 | 2008 | 405 | 0.710 |
Why?
|
Cognition | 16 | 2023 | 7073 | 0.670 |
Why?
|
Avoidance Learning | 3 | 2019 | 248 | 0.670 |
Why?
|
Cerebral Cortex | 19 | 2022 | 5812 | 0.620 |
Why?
|
Autonomic Nervous System | 3 | 2009 | 707 | 0.620 |
Why?
|
Positron-Emission Tomography | 24 | 2024 | 6669 | 0.590 |
Why?
|
Executive Function | 8 | 2023 | 1401 | 0.580 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 2015 | 36 | 0.570 |
Why?
|
Psychiatric Status Rating Scales | 20 | 2016 | 6029 | 0.560 |
Why?
|
Antidepressive Agents | 7 | 2024 | 2913 | 0.560 |
Why?
|
Reward | 7 | 2021 | 981 | 0.540 |
Why?
|
Mental Disorders | 7 | 2024 | 6874 | 0.540 |
Why?
|
Neurosurgical Procedures | 8 | 2023 | 2076 | 0.520 |
Why?
|
Behavior | 3 | 2018 | 542 | 0.520 |
Why?
|
Adult | 117 | 2024 | 223646 | 0.510 |
Why?
|
Arousal | 5 | 2009 | 1180 | 0.500 |
Why?
|
Psychotropic Drugs | 5 | 2018 | 881 | 0.480 |
Why?
|
Nerve Net | 8 | 2021 | 2352 | 0.470 |
Why?
|
Choice Behavior | 3 | 2019 | 848 | 0.460 |
Why?
|
Neural Pathways | 12 | 2024 | 3117 | 0.460 |
Why?
|
Implantable Neurostimulators | 5 | 2021 | 75 | 0.440 |
Why?
|
Neurosciences | 1 | 2018 | 383 | 0.440 |
Why?
|
Humans | 199 | 2024 | 768166 | 0.440 |
Why?
|
Affect | 7 | 2021 | 1495 | 0.430 |
Why?
|
Fluoxetine | 4 | 2012 | 733 | 0.420 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 8 | 2012 | 417 | 0.420 |
Why?
|
Consciousness | 3 | 2023 | 602 | 0.420 |
Why?
|
Young Adult | 41 | 2024 | 60066 | 0.410 |
Why?
|
Decision Making | 7 | 2019 | 3953 | 0.410 |
Why?
|
Electroencephalography | 6 | 2024 | 6314 | 0.410 |
Why?
|
Female | 121 | 2024 | 397192 | 0.390 |
Why?
|
Male | 113 | 2024 | 364719 | 0.390 |
Why?
|
Reaction Time | 10 | 2024 | 2101 | 0.390 |
Why?
|
Treatment Outcome | 49 | 2023 | 65371 | 0.380 |
Why?
|
Electrodes, Implanted | 5 | 2019 | 836 | 0.370 |
Why?
|
Models, Neurological | 5 | 2019 | 1776 | 0.370 |
Why?
|
Middle Aged | 73 | 2024 | 223492 | 0.360 |
Why?
|
Thiophenes | 1 | 2015 | 570 | 0.350 |
Why?
|
Depression | 12 | 2023 | 8230 | 0.350 |
Why?
|
Diprenorphine | 2 | 2014 | 13 | 0.340 |
Why?
|
Psychomotor Performance | 6 | 2019 | 1892 | 0.340 |
Why?
|
Concept Formation | 1 | 2011 | 160 | 0.340 |
Why?
|
Cerebrovascular Circulation | 10 | 2016 | 2725 | 0.330 |
Why?
|
Tourette Syndrome | 4 | 2016 | 400 | 0.320 |
Why?
|
Corpus Striatum | 7 | 2014 | 1224 | 0.310 |
Why?
|
Evoked Potentials | 4 | 2022 | 1058 | 0.310 |
Why?
|
Self-Injurious Behavior | 2 | 2021 | 568 | 0.300 |
Why?
|
Depressive Disorder | 10 | 2016 | 3721 | 0.300 |
Why?
|
Acupuncture Analgesia | 1 | 2008 | 63 | 0.300 |
Why?
|
Anxiety | 7 | 2024 | 4672 | 0.290 |
Why?
|
Bayes Theorem | 6 | 2022 | 2359 | 0.290 |
Why?
|
Stereotypic Movement Disorder | 1 | 2007 | 31 | 0.290 |
Why?
|
Basal Ganglia | 3 | 2021 | 553 | 0.290 |
Why?
|
Psychiatric Somatic Therapies | 1 | 2007 | 2 | 0.290 |
Why?
|
Nucleus Accumbens | 3 | 2019 | 358 | 0.280 |
Why?
|
Electroconvulsive Therapy | 3 | 2017 | 505 | 0.270 |
Why?
|
Psychiatry | 1 | 2019 | 1716 | 0.270 |
Why?
|
Electromagnetic Fields | 2 | 2019 | 289 | 0.270 |
Why?
|
Mental Recall | 4 | 2017 | 1226 | 0.270 |
Why?
|
Behavior, Animal | 1 | 2014 | 1862 | 0.260 |
Why?
|
Primates | 3 | 2019 | 520 | 0.260 |
Why?
|
Memory | 3 | 2017 | 2208 | 0.260 |
Why?
|
Cocaine | 6 | 2012 | 947 | 0.250 |
Why?
|
Individuality | 2 | 2019 | 307 | 0.250 |
Why?
|
Sertraline | 2 | 2006 | 209 | 0.250 |
Why?
|
Ablation Techniques | 1 | 2008 | 255 | 0.240 |
Why?
|
Electric Stimulation | 4 | 2022 | 1741 | 0.240 |
Why?
|
Double-Blind Method | 9 | 2024 | 12465 | 0.230 |
Why?
|
Receptors, Dopamine D1 | 1 | 2006 | 277 | 0.230 |
Why?
|
Memory, Short-Term | 3 | 2016 | 1008 | 0.230 |
Why?
|
Benzazepines | 1 | 2006 | 308 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2021 | 9015 | 0.220 |
Why?
|
Models, Psychological | 2 | 2019 | 825 | 0.210 |
Why?
|
Telencephalon | 1 | 2003 | 143 | 0.210 |
Why?
|
Hypothalamus | 2 | 2021 | 1004 | 0.200 |
Why?
|
Placebo Effect | 4 | 2021 | 517 | 0.200 |
Why?
|
Neuropsychological Tests | 12 | 2021 | 7140 | 0.200 |
Why?
|
Parietal Lobe | 4 | 2023 | 866 | 0.200 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2019 | 3729 | 0.190 |
Why?
|
Analgesia | 2 | 2021 | 460 | 0.190 |
Why?
|
Anxiety Disorders | 5 | 2022 | 2748 | 0.190 |
Why?
|
Dihematoporphyrin Ether | 1 | 2001 | 33 | 0.190 |
Why?
|
Apathy | 1 | 2022 | 107 | 0.180 |
Why?
|
Methylphenidate | 3 | 2011 | 480 | 0.180 |
Why?
|
Photic Stimulation | 5 | 2019 | 1997 | 0.180 |
Why?
|
Analysis of Variance | 6 | 2021 | 6229 | 0.180 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2020 | 1489 | 0.180 |
Why?
|
Severity of Illness Index | 14 | 2022 | 15948 | 0.180 |
Why?
|
Dominance, Cerebral | 5 | 2008 | 623 | 0.170 |
Why?
|
Catheter Ablation | 2 | 2013 | 2780 | 0.170 |
Why?
|
Combined Modality Therapy | 7 | 2024 | 8542 | 0.170 |
Why?
|
Neurosurgery | 2 | 2023 | 682 | 0.170 |
Why?
|
Carbon Radioisotopes | 4 | 2011 | 567 | 0.170 |
Why?
|
Imagination | 3 | 2000 | 226 | 0.170 |
Why?
|
Mesencephalon | 1 | 2021 | 338 | 0.170 |
Why?
|
Parkinson Disease | 3 | 2024 | 2893 | 0.160 |
Why?
|
Single-Blind Method | 3 | 2017 | 1587 | 0.160 |
Why?
|
Radiosurgery | 1 | 2008 | 1330 | 0.150 |
Why?
|
Brain Stem | 2 | 2021 | 859 | 0.150 |
Why?
|
Membrane Transport Proteins | 2 | 2005 | 1037 | 0.150 |
Why?
|
Caudate Nucleus | 3 | 2015 | 391 | 0.150 |
Why?
|
Algorithms | 9 | 2019 | 14164 | 0.150 |
Why?
|
Meditation | 2 | 2011 | 257 | 0.150 |
Why?
|
Pain | 3 | 2021 | 5100 | 0.150 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 6 | 2009 | 1140 | 0.150 |
Why?
|
Motor Cortex | 2 | 2024 | 1013 | 0.150 |
Why?
|
Adolescent | 27 | 2022 | 89169 | 0.140 |
Why?
|
Microelectrodes | 3 | 2013 | 305 | 0.140 |
Why?
|
Propofol | 1 | 2023 | 608 | 0.140 |
Why?
|
Treatment Failure | 2 | 2015 | 2661 | 0.140 |
Why?
|
Hyperalgesia | 1 | 2021 | 527 | 0.140 |
Why?
|
Punishment | 2 | 2014 | 95 | 0.140 |
Why?
|
Verbal Learning | 3 | 2017 | 465 | 0.140 |
Why?
|
Radioligand Assay | 3 | 2012 | 366 | 0.140 |
Why?
|
Verbal Behavior | 2 | 2011 | 336 | 0.130 |
Why?
|
Pain Measurement | 3 | 2015 | 3583 | 0.130 |
Why?
|
Vagus Nerve Stimulation | 2 | 2017 | 228 | 0.130 |
Why?
|
Stereotaxic Techniques | 4 | 2019 | 553 | 0.130 |
Why?
|
Delphi Technique | 1 | 2020 | 891 | 0.130 |
Why?
|
Statistical Distributions | 1 | 2015 | 62 | 0.130 |
Why?
|
Predictive Value of Tests | 8 | 2015 | 15454 | 0.120 |
Why?
|
Prostheses and Implants | 2 | 2021 | 1276 | 0.120 |
Why?
|
Biogenic Monoamines | 1 | 1995 | 50 | 0.120 |
Why?
|
Nerve Tissue | 1 | 1995 | 78 | 0.120 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 6 | 2017 | 1988 | 0.120 |
Why?
|
Diffusion Tensor Imaging | 3 | 2021 | 2420 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1008 | 0.120 |
Why?
|
Photochemotherapy | 1 | 2001 | 830 | 0.110 |
Why?
|
Computer Simulation | 4 | 2024 | 6283 | 0.110 |
Why?
|
Safety | 1 | 2019 | 1159 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13490 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2011 | 10760 | 0.110 |
Why?
|
Pilot Projects | 8 | 2018 | 8741 | 0.110 |
Why?
|
Cognition Disorders | 3 | 2014 | 3980 | 0.110 |
Why?
|
Skin | 1 | 2007 | 4503 | 0.110 |
Why?
|
Psychotherapy, Brief | 1 | 2014 | 118 | 0.110 |
Why?
|
Cues | 4 | 2015 | 878 | 0.110 |
Why?
|
Heart Rate | 5 | 2009 | 4214 | 0.110 |
Why?
|
Aged | 23 | 2024 | 171504 | 0.110 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 3711 | 0.110 |
Why?
|
Surgery, Computer-Assisted | 2 | 2016 | 1003 | 0.110 |
Why?
|
Cerebrum | 1 | 2014 | 132 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2017 | 39348 | 0.110 |
Why?
|
Self Report | 3 | 2022 | 3773 | 0.110 |
Why?
|
Frontal Lobe | 5 | 2014 | 1426 | 0.110 |
Why?
|
Comorbidity | 8 | 2021 | 10590 | 0.100 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2011 | 287 | 0.100 |
Why?
|
Longitudinal Studies | 6 | 2015 | 14783 | 0.100 |
Why?
|
Risk-Taking | 1 | 2018 | 1023 | 0.100 |
Why?
|
Neostriatum | 2 | 2008 | 236 | 0.100 |
Why?
|
Frontotemporal Dementia | 1 | 2015 | 249 | 0.100 |
Why?
|
Neurons | 5 | 2020 | 9514 | 0.100 |
Why?
|
Receptors, Serotonin, 5-HT2 | 1 | 2012 | 6 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2012 | 2055 | 0.100 |
Why?
|
Radionuclide Imaging | 3 | 2012 | 2000 | 0.100 |
Why?
|
Body Dysmorphic Disorders | 1 | 2016 | 243 | 0.100 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2012 | 98 | 0.100 |
Why?
|
Psychophysics | 2 | 2015 | 291 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4413 | 0.090 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2014 | 4640 | 0.090 |
Why?
|
Dopamine | 2 | 2010 | 1592 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3436 | 0.090 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3081 | 0.090 |
Why?
|
Models, Theoretical | 3 | 2018 | 3573 | 0.090 |
Why?
|
Estradiol | 2 | 2008 | 1951 | 0.090 |
Why?
|
Semantics | 3 | 2011 | 618 | 0.090 |
Why?
|
Vietnam Conflict | 1 | 2011 | 101 | 0.090 |
Why?
|
Raclopride | 1 | 2010 | 102 | 0.090 |
Why?
|
Electrodes | 3 | 2019 | 617 | 0.090 |
Why?
|
Oxygen Radioisotopes | 1 | 2010 | 75 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.090 |
Why?
|
Radiopharmaceuticals | 6 | 2012 | 2735 | 0.090 |
Why?
|
Behavior Therapy | 2 | 2014 | 886 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2004 | 702 | 0.080 |
Why?
|
Ventral Tegmental Area | 1 | 2010 | 135 | 0.080 |
Why?
|
Hot Flashes | 1 | 2012 | 330 | 0.080 |
Why?
|
Statistics as Topic | 2 | 2014 | 2357 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2491 | 0.080 |
Why?
|
Central Nervous System Stimulants | 3 | 2010 | 1168 | 0.080 |
Why?
|
Pyrimidinones | 1 | 2012 | 386 | 0.080 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20227 | 0.080 |
Why?
|
Learning | 2 | 2017 | 1759 | 0.080 |
Why?
|
Substantia Nigra | 1 | 2010 | 346 | 0.080 |
Why?
|
Reference Values | 4 | 2006 | 4938 | 0.080 |
Why?
|
Fluorine Radioisotopes | 1 | 2012 | 425 | 0.080 |
Why?
|
Hot Temperature | 1 | 2015 | 1441 | 0.080 |
Why?
|
Intelligence Tests | 1 | 2010 | 504 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1436 | 0.080 |
Why?
|
Personality Inventory | 3 | 2008 | 1018 | 0.080 |
Why?
|
Nipecotic Acids | 1 | 2008 | 36 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20760 | 0.080 |
Why?
|
Aggression | 2 | 2006 | 750 | 0.070 |
Why?
|
Temporal Lobe | 3 | 2007 | 1726 | 0.070 |
Why?
|
Hippocampus | 3 | 2017 | 3785 | 0.070 |
Why?
|
Radio Waves | 2 | 2019 | 250 | 0.070 |
Why?
|
Animals | 13 | 2019 | 169246 | 0.070 |
Why?
|
Pons | 1 | 2008 | 242 | 0.070 |
Why?
|
Regional Blood Flow | 3 | 2006 | 1500 | 0.070 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1462 | 0.070 |
Why?
|
Carrier Proteins | 1 | 1999 | 4937 | 0.070 |
Why?
|
Task Performance and Analysis | 3 | 2018 | 771 | 0.070 |
Why?
|
Case-Control Studies | 7 | 2014 | 22291 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2016 | 4063 | 0.070 |
Why?
|
Neurotic Disorders | 1 | 2006 | 77 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2014 | 491 | 0.060 |
Why?
|
Hydrocortisone | 3 | 2020 | 1841 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 54926 | 0.060 |
Why?
|
Amplifiers, Electronic | 2 | 2015 | 16 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 500 | 0.060 |
Why?
|
Luteinizing Hormone | 1 | 2008 | 822 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2023 | 81762 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1312 | 0.060 |
Why?
|
Program Evaluation | 1 | 2014 | 2507 | 0.060 |
Why?
|
Somatoform Disorders | 1 | 2008 | 425 | 0.060 |
Why?
|
Thinking | 2 | 2023 | 320 | 0.060 |
Why?
|
Attention | 2 | 2008 | 2424 | 0.060 |
Why?
|
Chronic Disease | 3 | 2017 | 9384 | 0.060 |
Why?
|
Desensitization, Psychologic | 1 | 2004 | 27 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2815 | 0.060 |
Why?
|
Electrocardiography | 2 | 2009 | 6412 | 0.060 |
Why?
|
Intelligence | 1 | 2010 | 926 | 0.060 |
Why?
|
Facial Expression | 1 | 2008 | 515 | 0.060 |
Why?
|
Epilepsy | 2 | 2016 | 3327 | 0.060 |
Why?
|
Menopause | 2 | 2012 | 1656 | 0.060 |
Why?
|
Vagus Nerve | 1 | 2007 | 459 | 0.060 |
Why?
|
Psychophysiology | 1 | 2004 | 137 | 0.060 |
Why?
|
Employment | 1 | 2010 | 1110 | 0.060 |
Why?
|
Alleles | 2 | 2012 | 6894 | 0.060 |
Why?
|
Veterans | 2 | 2011 | 2669 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 944 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6316 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2931 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2862 | 0.050 |
Why?
|
Memory Disorders | 3 | 2005 | 1200 | 0.050 |
Why?
|
Body Image | 1 | 2008 | 646 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2001 | 9419 | 0.050 |
Why?
|
Rest | 2 | 2018 | 948 | 0.050 |
Why?
|
Fluvoxamine | 1 | 2002 | 78 | 0.050 |
Why?
|
Functional Laterality | 3 | 2004 | 2264 | 0.050 |
Why?
|
Brain Diseases | 1 | 2012 | 1554 | 0.050 |
Why?
|
Irritable Mood | 1 | 2004 | 196 | 0.050 |
Why?
|
Respiration | 1 | 2009 | 1665 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 826 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 2004 | 223 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2011 | 5315 | 0.050 |
Why?
|
Autistic Disorder | 1 | 2012 | 1240 | 0.050 |
Why?
|
Drug Resistance | 3 | 2021 | 1599 | 0.050 |
Why?
|
Receptors, Dopamine | 1 | 2002 | 293 | 0.050 |
Why?
|
Placebos | 1 | 2006 | 1667 | 0.050 |
Why?
|
Oxygen | 2 | 2011 | 4270 | 0.050 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 211 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4423 | 0.050 |
Why?
|
Magnetics | 1 | 2004 | 597 | 0.050 |
Why?
|
Mood Disorders | 2 | 2006 | 1129 | 0.050 |
Why?
|
Estrogens | 1 | 2008 | 1536 | 0.050 |
Why?
|
Unconsciousness | 1 | 2023 | 251 | 0.050 |
Why?
|
Delayed-Action Preparations | 3 | 2011 | 969 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2008 | 1542 | 0.050 |
Why?
|
Prolactin | 2 | 2008 | 627 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 299 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2004 | 555 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 2005 | 508 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2004 | 4860 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3347 | 0.040 |
Why?
|
Guilt | 1 | 2000 | 93 | 0.040 |
Why?
|
Radiography | 2 | 2008 | 6983 | 0.040 |
Why?
|
Florida | 2 | 2011 | 417 | 0.040 |
Why?
|
Problem Solving | 1 | 2002 | 443 | 0.040 |
Why?
|
Software | 3 | 2020 | 4478 | 0.040 |
Why?
|
Life Change Events | 1 | 2004 | 960 | 0.040 |
Why?
|
Libido | 1 | 1999 | 124 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3239 | 0.040 |
Why?
|
Organ Size | 2 | 2015 | 2267 | 0.040 |
Why?
|
Consciousness Disorders | 1 | 2023 | 445 | 0.040 |
Why?
|
Medicaid | 1 | 2011 | 2840 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10399 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2019 | 360 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 13014 | 0.040 |
Why?
|
Social Adjustment | 2 | 2016 | 635 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13676 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 13053 | 0.040 |
Why?
|
Thorax | 1 | 2001 | 557 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2021 | 648 | 0.040 |
Why?
|
Triazoles | 1 | 2002 | 904 | 0.040 |
Why?
|
Pimozide | 1 | 1996 | 21 | 0.040 |
Why?
|
Equipment Design | 2 | 2015 | 3522 | 0.030 |
Why?
|
Time Factors | 4 | 2014 | 40218 | 0.030 |
Why?
|
Serial Learning | 1 | 1997 | 42 | 0.030 |
Why?
|
Anti-Dyskinesia Agents | 1 | 1996 | 24 | 0.030 |
Why?
|
Dopamine Agents | 1 | 1998 | 188 | 0.030 |
Why?
|
Interferon Inducers | 1 | 1996 | 24 | 0.030 |
Why?
|
Random Allocation | 1 | 2021 | 2396 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2023 | 1189 | 0.030 |
Why?
|
Poly I-C | 1 | 1996 | 111 | 0.030 |
Why?
|
Action Potentials | 2 | 2015 | 1838 | 0.030 |
Why?
|
Memory, Long-Term | 1 | 2016 | 61 | 0.030 |
Why?
|
Analog-Digital Conversion | 1 | 2015 | 23 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2015 | 22 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2013 | 15832 | 0.030 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2001 | 558 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2024 | 1162 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18349 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2019 | 680 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2011 | 4530 | 0.030 |
Why?
|
1-Naphthylamine | 1 | 1995 | 48 | 0.030 |
Why?
|
Miniaturization | 1 | 2015 | 154 | 0.030 |
Why?
|
Haloperidol | 1 | 1996 | 394 | 0.030 |
Why?
|
Electric Power Supplies | 1 | 2015 | 96 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1995 | 170 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.030 |
Why?
|
Serotonin Antagonists | 1 | 1995 | 147 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2415 | 0.030 |
Why?
|
United States | 6 | 2023 | 73039 | 0.030 |
Why?
|
Haplorhini | 1 | 2015 | 523 | 0.030 |
Why?
|
Diagnostic Imaging | 2 | 2006 | 3533 | 0.030 |
Why?
|
Receptors, Opioid | 1 | 2014 | 145 | 0.030 |
Why?
|
Pineal Gland | 1 | 1995 | 158 | 0.030 |
Why?
|
Electronics | 1 | 2015 | 317 | 0.030 |
Why?
|
Postoperative Period | 2 | 2013 | 1826 | 0.030 |
Why?
|
Glucose | 3 | 2012 | 4352 | 0.030 |
Why?
|
Putamen | 1 | 2014 | 291 | 0.030 |
Why?
|
Head | 1 | 2019 | 926 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2001 | 21206 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 13090 | 0.030 |
Why?
|
Motivation | 2 | 2014 | 2020 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 1995 | 309 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2014 | 219 | 0.030 |
Why?
|
Conditioning, Classical | 1 | 2015 | 368 | 0.030 |
Why?
|
Atrophy | 2 | 2012 | 1646 | 0.030 |
Why?
|
Feedback | 1 | 2016 | 799 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10632 | 0.030 |
Why?
|
Catatonia | 1 | 2015 | 181 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2019 | 1407 | 0.020 |
Why?
|
Adrenal Glands | 1 | 1995 | 557 | 0.020 |
Why?
|
Norepinephrine | 1 | 1995 | 898 | 0.020 |
Why?
|
Minisatellite Repeats | 1 | 2012 | 162 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2019 | 2363 | 0.020 |
Why?
|
Pyridines | 1 | 2024 | 2894 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2130 | 0.020 |
Why?
|
Anorexia Nervosa | 1 | 2001 | 1364 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 8054 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2004 | 619 | 0.020 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2012 | 108 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.020 |
Why?
|
Astrocytoma | 1 | 1996 | 774 | 0.020 |
Why?
|
Blood Pressure | 1 | 2007 | 8543 | 0.020 |
Why?
|
Blood Glucose | 1 | 2006 | 6430 | 0.020 |
Why?
|
Prevalence | 3 | 2020 | 15869 | 0.020 |
Why?
|
Administration, Oral | 2 | 2011 | 4030 | 0.020 |
Why?
|
Language Disorders | 1 | 2012 | 140 | 0.020 |
Why?
|
Medial Forebrain Bundle | 1 | 2010 | 42 | 0.020 |
Why?
|
Electric Impedance | 1 | 2015 | 794 | 0.020 |
Why?
|
Personality Disorders | 1 | 2015 | 726 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2512 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 515 | 0.020 |
Why?
|
Body Temperature Regulation | 1 | 2012 | 292 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14729 | 0.020 |
Why?
|
Serotonin | 1 | 1995 | 1043 | 0.020 |
Why?
|
Electrophysiology | 1 | 2013 | 1266 | 0.020 |
Why?
|
Transforming Growth Factors | 1 | 1989 | 76 | 0.020 |
Why?
|
Linear Models | 2 | 2015 | 5884 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2016 | 1474 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3800 | 0.020 |
Why?
|
Psychological Tests | 1 | 2012 | 643 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 591 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2732 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1995 | 1243 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2016 | 1078 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3628 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 16045 | 0.020 |
Why?
|
Psychotherapy, Group | 1 | 2012 | 417 | 0.020 |
Why?
|
Research Design | 1 | 2004 | 6211 | 0.020 |
Why?
|
Hormones | 1 | 2012 | 866 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 2015 | 1649 | 0.020 |
Why?
|
Rats | 2 | 2014 | 23760 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 8080 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2000 | 3205 | 0.020 |
Why?
|
Hostility | 1 | 2008 | 185 | 0.020 |
Why?
|
Awareness | 1 | 2011 | 654 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9613 | 0.020 |
Why?
|
Logistic Models | 2 | 2015 | 13290 | 0.020 |
Why?
|
Anisotropy | 1 | 2010 | 1292 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2011 | 744 | 0.020 |
Why?
|
Lymphocytes | 1 | 1995 | 2614 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2008 | 326 | 0.020 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 13045 | 0.020 |
Why?
|
Cohort Studies | 4 | 2015 | 41754 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2008 | 482 | 0.020 |
Why?
|
Motor Activity | 1 | 1995 | 2711 | 0.010 |
Why?
|
Phenotype | 2 | 2016 | 16726 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5107 | 0.010 |
Why?
|
Wechsler Scales | 1 | 2005 | 256 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6340 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 2005 | 458 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2007 | 550 | 0.010 |
Why?
|
Forecasting | 2 | 2004 | 2945 | 0.010 |
Why?
|
Oximes | 1 | 2005 | 303 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2006 | 376 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8128 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2230 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2009 | 937 | 0.010 |
Why?
|
Drug Costs | 1 | 2011 | 1195 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1997 | 0.010 |
Why?
|
Substance Abuse Detection | 1 | 2006 | 301 | 0.010 |
Why?
|
Vietnam | 1 | 2004 | 415 | 0.010 |
Why?
|
Molecular Imaging | 1 | 2009 | 826 | 0.010 |
Why?
|
Outpatients | 1 | 2011 | 1600 | 0.010 |
Why?
|
Glioma | 2 | 1989 | 3503 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4249 | 0.010 |
Why?
|
Age Factors | 2 | 2011 | 18412 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11095 | 0.010 |
Why?
|
Glioblastoma | 1 | 1996 | 3464 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12543 | 0.010 |
Why?
|
Single-Cell Analysis | 1 | 2012 | 2540 | 0.010 |
Why?
|
Behavior, Addictive | 1 | 2006 | 428 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.010 |
Why?
|
Binding Sites | 2 | 2002 | 6020 | 0.010 |
Why?
|
Aging | 1 | 1999 | 8744 | 0.010 |
Why?
|
Hypnosis | 1 | 2001 | 84 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1996 | 9118 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2253 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1485 | 0.010 |
Why?
|
Patient Compliance | 1 | 2009 | 2697 | 0.010 |
Why?
|
Interferon-beta | 1 | 2001 | 349 | 0.010 |
Why?
|
Pemoline | 1 | 1998 | 18 | 0.010 |
Why?
|
Globus Pallidus | 1 | 1999 | 248 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2005 | 1434 | 0.010 |
Why?
|
Cell Division | 1 | 1985 | 4473 | 0.010 |
Why?
|
Urinary Incontinence | 1 | 2002 | 490 | 0.010 |
Why?
|
Physician's Role | 1 | 2004 | 925 | 0.010 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2001 | 879 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5926 | 0.010 |
Why?
|
Schizophrenia | 1 | 2015 | 6983 | 0.010 |
Why?
|
Child | 2 | 2022 | 80917 | 0.010 |
Why?
|
Carboxymethylcellulose Sodium | 1 | 1996 | 38 | 0.010 |
Why?
|
Food | 1 | 2001 | 768 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3390 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 1996 | 145 | 0.010 |
Why?
|
Psychometrics | 1 | 2006 | 3063 | 0.010 |
Why?
|
Polylysine | 1 | 1996 | 130 | 0.010 |
Why?
|
Recurrence | 1 | 2008 | 8509 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2001 | 59629 | 0.010 |
Why?
|
Self Concept | 1 | 2001 | 1043 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2006 | 2907 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2001 | 1835 | 0.010 |
Why?
|
Drug Synergism | 1 | 1998 | 1760 | 0.010 |
Why?
|
Preoperative Care | 1 | 2001 | 2258 | 0.010 |
Why?
|
Energy Intake | 1 | 2000 | 2146 | 0.010 |
Why?
|
Piperazines | 1 | 2002 | 2554 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2004 | 2517 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1996 | 2107 | 0.010 |
Why?
|
Agar | 1 | 1989 | 51 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1989 | 153 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2001 | 2663 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1989 | 486 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1989 | 636 | 0.010 |
Why?
|
Health Status | 1 | 2001 | 4091 | 0.000 |
Why?
|
Culture Media | 1 | 1989 | 898 | 0.000 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1996 | 3556 | 0.000 |
Why?
|
Risk Factors | 1 | 2012 | 74944 | 0.000 |
Why?
|
Thymidine | 1 | 1985 | 297 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1989 | 6124 | 0.000 |
Why?
|
Survival Rate | 1 | 1996 | 12840 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 1998 | 7454 | 0.000 |
Why?
|
Prognosis | 1 | 2001 | 30010 | 0.000 |
Why?
|
Fibroblasts | 1 | 1989 | 4176 | 0.000 |
Why?
|
Kinetics | 1 | 1985 | 6329 | 0.000 |
Why?
|
Kidney | 1 | 1989 | 7064 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1985 | 19015 | 0.000 |
Why?
|